Unique mutation portraits and frequent COL2A1 gene alteration in chondrosarcoma
- Yasushi Totoki1,
- Akihiko Yoshida2,
- Fumie Hosoda1,
- Hiromi Nakamura1,
- Natsuko Hama1,
- Koichi Ogura2,
- Aki Yoshida3,
- Tomohiro Fujiwara2,
- Yasuhito Arai1,
- Junya Toguchida4,
- Hitoshi Tsuda2,
- Satoru Miyano5,
- Akira Kawai2 and
- Tatsuhiro Shibata1,6
- 1 National Cancer Center Research Institute;
- 2 National Cancer Center Hospital;
- 3 Okayama University;
- 4 Kyoto University;
- 5 The University of Tokyo
- ↵* Corresponding author; email: tashibat{at}ncc.go.jp
Abstract
Chondrosarcoma is the second most frequent malignant bone tumor. However, the etiological background of chondrosarcomagenesis remains largely unknown, along with detailed information on molecular alterations, including potential therapeutic targets. Massively parallel paired-end sequencing of whole genomes of ten primary chondrosarcomas revealed that the process of accumulation of somatic mutations is homogeneous irrespective of pathological subtype or the presence of IDH1 mutation and unique among a range of cancer types, and shares significant commonalities with that of prostate cancer. Clusters of structural alterations localized within a single chromosome were observed in four cases. Combined with targeted resequencing of additional cartilaginous tumor cohort, we identified somatic alterations of the COL2A1 gene, which encodes an essential extracellular matrix protein in chondro-skeletal development, in 19.3% of chondrosarcoma and 31.7% of enchondroma cases. Epigenetic regulators (IDH1 and YEATS2) and an activin/BMP signal component (ACVR2A) were recurrently altered. Furthermore, a novel FN1-ACVR2A fusion transcript was observed in both chondrosarcoma and osteochondromatosis cases. Under the characteristic accumulative process of somatic changes as a background, molecular defects in chondrogenesis and aberrant epigenetic control are primarily causative of both benign and malignant cartilaginous tumors.
- Received May 15, 2013.
- Accepted June 23, 2014.
- Published by Cold Spring Harbor Laboratory Press
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml). After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.
